CG Oncology (CGON) Current Leases (2023 - 2026)

CG Oncology posted quarterly Current Leases of $1.1 million for Q1 2026, up 318.04% year-on-year from $255000.0 in Q1 2025, and up 16.5% on a QoQ basis from $915000.0 in Q4 2025.

CG Oncology (CGON) has 4 years of Current Leases data on file, last reported at $1.1 million in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases rose 318.04% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (up 318.04% YoY), and the FY2025 full-year result was $915000.0, up 391.94% from the prior year.
  • Current Leases for Q1 2026 stood at $1.1 million, up from $915000.0 in the prior quarter.
  • Across five years, Current Leases topped out at $1.1 million in Q1 2026 and bottomed at $186000.0 in Q4 2024.
  • The 4-year median for Current Leases is $246000.0 (2024), against an average of $452100.0.
  • The widest annual swing landed in 2024, when Current Leases retreated 14.29%; it then soared 391.94% in 2025.
  • A 4-year view of Current Leases shows it stood at $217000.0 in 2023, then slipped by 14.29% to $186000.0 in 2024, then jumped by 391.94% to $915000.0 in 2025, then gained by 16.5% to $1.1 million in 2026.
  • The last three Current Leases figures came in at $1.1 million (Q1 2026), $915000.0 (Q4 2025), and $912000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 83,991.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 7.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 720.00 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.66 Mn
10 CG Oncology 5.01 Bn 5.01 Bn -1.88 Mn 1.07 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.07 Mn
Dec 31, 2025 915,000.00
Sep 30, 2025 912,000.00
Jun 30, 2025 288,000.00
Mar 31, 2025 255,000.00
Dec 31, 2024 186,000.00
Sep 30, 2024 225,000.00
Jun 30, 2024 237,000.00
Mar 31, 2024 220,000.00
Dec 31, 2023 217,000.00